SAB Biotherapeutics

0 followers

‌

SAB Biotherapeutics is advancing a new class of immunotherapies with targeted, fully human polyclonal antibodies for the treatment of Covid-19, diabetes, organ transplant & flu.

Industries

Employees

51-200

Links


Org chart

Eddie J. Sullivan
Co-Founder, President & CEO
Collapse
Christoph Bausch
Executive Vice President & Chief Operating Officer
Alexandra Kropotova
EVP, Chief Medical Officer
Dr. Carlos Carrillo, MS, PhD.
SVP Of Regulatory Affairs/quality Assurance At SAB Biotherapeutics
Angela Parizek
Vice President, Clinical Operations
Trenton Klimper
Executive Director of Financial Reporting
Katie Ellias
Board Member
Lucy To
Chief Financial Officer
Catherine Derose Shrm-Scp
Vice President Human Resources
Sheila Carlson
Senior Executive Assistant To The CEO

Board & advisors

Samuel J. Reich
Chairman & CEO
David Link
Vice Chairman
Christine Hamilton
Co-Founder & Board Member
Eddie Hamilton
Co-Founder, Board Member
Bill Polvino
Board Member
Scott Giberson
Board Member
William J. Polvino
Board Member
Erick Lucera
Director